Skip to main content

News

Press Release
11/26/2013
Topera, Inc., a medical device company that has developed a novel mapping system, shared the results of an independent evaluation of its diagnostic system’s ability to improve AF outcomes by identifying of the sources that sustain complex...
Topera, Inc., a medical device company that has developed a novel mapping system, shared the results of an independent evaluation of its diagnostic system’s ability to improve AF outcomes by identifying of the sources that sustain complex...
Topera, Inc., a medical device...
11/26/2013
EP Lab Digest
Press Release
11/21/2013
BIOTRONIK, a leading manufacturer of cardiovascular medical devices, announced that the U.S. Food and Drug Administration (FDA) has approved an expansion of their ongoing ProMRI® trial. The just-completed Phase A of the trial evaluated the...
BIOTRONIK, a leading manufacturer of cardiovascular medical devices, announced that the U.S. Food and Drug Administration (FDA) has approved an expansion of their ongoing ProMRI® trial. The just-completed Phase A of the trial evaluated the...
BIOTRONIK, a leading...
11/21/2013
EP Lab Digest
Press Release
11/20/2013
Physio-Control, the world leader in emergency medical response technologies, announced that the comprehensive results of the LUCAS in Cardiac Arrest (LINC) clinical trial have been published in the prestigious Journal of the American Medical...
Physio-Control, the world leader in emergency medical response technologies, announced that the comprehensive results of the LUCAS in Cardiac Arrest (LINC) clinical trial have been published in the prestigious Journal of the American Medical...
Physio-Control, the world leader...
11/20/2013
EP Lab Digest
Press Release
11/20/2013
New research shows that Medtronic, Inc. pacemakers with enhanced pacing features have the ability to slow the progression of atrial fibrillation (AF) in patients with bradycardia. Presented as a late breaking clinical trial at the American...
New research shows that Medtronic, Inc. pacemakers with enhanced pacing features have the ability to slow the progression of atrial fibrillation (AF) in patients with bradycardia. Presented as a late breaking clinical trial at the American...
New research shows that...
11/20/2013
EP Lab Digest
Press Release
11/20/2013
A recent study presented by Ken Thigpen, RRT (St. Dominic-Jackson Memorial Hospital; Jackson, Mississippi) at the 2013 American Heart Association (AHA) Scientific Sessions found that use of the ResQPOD® Impedance Threshold Device (ITD),...
A recent study presented by Ken Thigpen, RRT (St. Dominic-Jackson Memorial Hospital; Jackson, Mississippi) at the 2013 American Heart Association (AHA) Scientific Sessions found that use of the ResQPOD® Impedance Threshold Device (ITD),...
A recent study presented by Ken...
11/20/2013
EP Lab Digest
Press Release
11/20/2013
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced results from the phase 3 ENGAGE AF-TIMI 48 study.(1) This clinical trial found that the investigational, oral, once-daily direct factor Xa-inhibitor edoxaban met the...
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced results from the phase 3 ENGAGE AF-TIMI 48 study.(1) This clinical trial found that the investigational, oral, once-daily direct factor Xa-inhibitor edoxaban met the...
Daiichi Sankyo Company, Limited...
11/20/2013
EP Lab Digest
Press Release
11/19/2013
AtriClip™ Left Atrial Appendage Exclusion System to be Evaluated as Alternative to Anti-Coagulation Therapy AtriCure, Inc., a leading developer of solutions to treat atrial fibrillation (Afib), announced the Food and Drug Administration's...
AtriClip™ Left Atrial Appendage Exclusion System to be Evaluated as Alternative to Anti-Coagulation Therapy AtriCure, Inc., a leading developer of solutions to treat atrial fibrillation (Afib), announced the Food and Drug Administration's...
AtriClip™ Left Atrial Appendage...
11/19/2013
EP Lab Digest
Press Release
11/18/2013
ChanRx Presents Study Results at 2013 American Heart Association Scientific Sessions ChanRx, a pharmaceutical company developing medicines for cardiovascular diseases, announced positive safety and statistically significant efficacy data...
ChanRx Presents Study Results at 2013 American Heart Association Scientific Sessions ChanRx, a pharmaceutical company developing medicines for cardiovascular diseases, announced positive safety and statistically significant efficacy data...
ChanRx Presents Study Results at...
11/18/2013
EP Lab Digest
Press Release
11/15/2013
Will Support Resuscitation and Acute Critical Care Research and Educational Activities with a Focus on New Investigations November 15, 2013—CHELMSFORD, MASS.—ZOLL Medical Corporation, a manufacturer of medical devices and related software...
Will Support Resuscitation and Acute Critical Care Research and Educational Activities with a Focus on New Investigations November 15, 2013—CHELMSFORD, MASS.—ZOLL Medical Corporation, a manufacturer of medical devices and related software...
Will Support Resuscitation and...
11/15/2013
EP Lab Digest
Press Release
11/12/2013
ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced that its advanced resuscitation technology, which supports the American Heart Association’s increased focus on improving CPR quality to...
ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced that its advanced resuscitation technology, which supports the American Heart Association’s increased focus on improving CPR quality to...
ZOLL Medical Corporation, a...
11/12/2013
EP Lab Digest